More on Ofatumumab for TTP

N Engl J Med. 2018 Apr 5;378(14):1365. doi: 10.1056/NEJMc1801263.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal*
  • Antibodies, Monoclonal, Humanized
  • Antigens, CD20*
  • Antineoplastic Agents
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antigens, CD20
  • Antineoplastic Agents
  • ofatumumab